Literature DB >> 33002388

Imaging quality and prostate MR: it is time to improve.

Francesco Giganti1,2, Clare Allen1.   

Abstract

The Prostate Imaging Reporting and Data System (PI-RADS) guidelines set out the minimal technical requirements for the acquisition of multiparametric MRI (mpMRI) of the prostate. However, the rapid diffusion of this technique has inevitably led to variability in scan quality among centres across the UK and the world. Suboptimal image acquisition reduces the sensitivity and specificity of this technique for the detection of clinically significant prostate cancer and results in clinicians losing confidence in the technique.Two expert panels, one from the UK and one from the European Society of Urogenital Radiology (ESUR)/EAU Section of Urologic Imaging (ESUI), have stressed the importance to establish quality criteria for the acquisition of mpMRI of the prostate. A first attempt to address this issue has been the publication of the Prostate Imaging Quality (PI-QUAL) score, which assesses the mpMRI quality against a set of objective criteria (PI-RADS guidelines) together with criteria obtained from the image.PI-QUAL represents the first step towards the standardisation of a scoring system to assess the quality of prostate mpMRI prior to reporting and allows clinicians to have more confidence in using the scan to determine patient care. Further refinements after robust consensus among experts at an international level need to be agreed before its widespread adoption in the clinical setting.

Entities:  

Mesh:

Year:  2020        PMID: 33002388      PMCID: PMC7934318          DOI: 10.1259/bjr.20200934

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  22 in total

1.  Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists' Training.

Authors:  Maarten de Rooij; Bas Israël; Tristan Barrett; Francesco Giganti; Anwar R Padhani; Valeria Panebianco; Jonathan Richenberg; Georg Salomon; Ivo G Schoots; Geert Villeirs; Jochen Walz; Jelle O Barentsz
Journal:  Eur Urol       Date:  2020-06-24       Impact factor: 20.096

2.  Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.

Authors:  Francesco Giganti; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Eur Urol Oncol       Date:  2020-07-06

3.  PI-QUAL, a New System for Evaluating Prostate Magnetic Resonance Imaging Quality: Is Beauty in the Eye of the Beholder?

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Eur Urol Oncol       Date:  2020-07-30

4.  Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.

Authors:  Amirhossein Mohammadian Bajgiran; Sohrab Afshari Mirak; Kyunghyun Sung; Anthony E Sisk; Robert E Reiter; Steven S Raman
Journal:  AJR Am J Roentgenol       Date:  2019-06-19       Impact factor: 3.959

5.  DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.

Authors:  Francesco Giganti; Martina Pecoraro; Davide Fierro; Riccardo Campa; Francesco Del Giudice; Shonit Punwani; Alex Kirkham; Clare Allen; Mark Emberton; Carlo Catalano; Caroline M Moore; Valeria Panebianco
Journal:  Magn Reson Imaging       Date:  2019-12-30       Impact factor: 2.546

Review 6.  Prostate mpMRI in the UK: the state of the nation.

Authors:  C Davies; J T Castle; K Stalbow; P J Haslam
Journal:  Clin Radiol       Date:  2019-11       Impact factor: 2.350

7.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

8.  ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.

Authors:  Maarten de Rooij; Bas Israël; Marcia Tummers; Hashim U Ahmed; Tristan Barrett; Francesco Giganti; Bernd Hamm; Vibeke Løgager; Anwar Padhani; Valeria Panebianco; Philippe Puech; Jonathan Richenberg; Olivier Rouvière; Georg Salomon; Ivo Schoots; Jeroen Veltman; Geert Villeirs; Jochen Walz; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2020-05-19       Impact factor: 5.315

9.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

Review 10.  Optimization of prostate MRI acquisition and post-processing protocol: a pictorial review with access to acquisition protocols.

Authors:  Ivan Jambor
Journal:  Acta Radiol Open       Date:  2017-12-08
View more
  1 in total

Review 1.  Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.

Authors:  Francesco Giganti; Veeru Kasivisvanathan; Alex Kirkham; Shonit Punwani; Mark Emberton; Caroline M Moore; Clare Allen
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.